199 related articles for article (PubMed ID: 31981107)
1. Advanced Stages of Chronic Venous Disease: Evolution of Surgical Techniques and Advantages of Associated Medical Treatment.
Lurie F
Adv Ther; 2020 Feb; 37(Suppl 1):6-12. PubMed ID: 31981107
[TBL] [Abstract][Full Text] [Related]
2. The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease.
Nicolaides AN
Adv Ther; 2020 Feb; 37(Suppl 1):1-5. PubMed ID: 31970659
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for the medical management of chronic venous disease: The role of Micronized Purified Flavanoid Fraction (MPFF).
Bush R; Comerota A; Meissner M; Raffetto JD; Hahn SR; Freeman K
Phlebology; 2017 Apr; 32(1_suppl):3-19. PubMed ID: 28211296
[TBL] [Abstract][Full Text] [Related]
4. Early Stages of Chronic Venous Disease: Medical Treatment Alone or in Addition to Endovenous Treatments.
Mansilha A
Adv Ther; 2020 Feb; 37(Suppl 1):13-18. PubMed ID: 31981108
[TBL] [Abstract][Full Text] [Related]
5. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.
Gloviczki P; Comerota AJ; Dalsing MC; Eklof BG; Gillespie DL; Gloviczki ML; Lohr JM; McLafferty RB; Meissner MH; Murad MH; Padberg FT; Pappas PJ; Passman MA; Raffetto JD; Vasquez MA; Wakefield TW; ;
J Vasc Surg; 2011 May; 53(5 Suppl):2S-48S. PubMed ID: 21536172
[TBL] [Abstract][Full Text] [Related]
6. CHIVA method for the treatment of chronic venous insufficiency.
Bellmunt-Montoya S; Escribano JM; Pantoja Bustillos PE; Tello-Díaz C; Martinez-Zapata MJ
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD009648. PubMed ID: 34590305
[TBL] [Abstract][Full Text] [Related]
7. Benefits of venoactive drug therapy in surgical or endovenous treatment for varicose veins: a systematic review.
Mansilha A; Sousa J
Int Angiol; 2019 Aug; 38(4):291-298. PubMed ID: 31284708
[TBL] [Abstract][Full Text] [Related]
8. The Most Severe Stage of Chronic Venous Disease: An Update on the Management of Patients with Venous Leg Ulcers.
Nicolaides AN
Adv Ther; 2020 Feb; 37(Suppl 1):19-24. PubMed ID: 31970660
[TBL] [Abstract][Full Text] [Related]
9. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.
Ulloa JH
Adv Ther; 2019 Mar; 36(Suppl 1):20-25. PubMed ID: 30758743
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder].
Hnátek L
Vnitr Lek; 2015 Sep; 61(9):807-14. PubMed ID: 26465280
[TBL] [Abstract][Full Text] [Related]
11. Is There a Difference in the Clinical Efficacy of Diosmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Disorders? Review of Available Evidence.
Cazaubon M; Benigni JP; Steinbruch M; Jabbour V; Gouhier-Kodas C
Vasc Health Risk Manag; 2021; 17():591-600. PubMed ID: 34556990
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
Kakkos SK; Nicolaides AN
Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of endovenous laser and glue ablation methods in comparison with conventional surgery for the treatment of venous ulcers.
Erdinc I
Phlebology; 2022 Oct; 37(9):670-677. PubMed ID: 36063058
[TBL] [Abstract][Full Text] [Related]
14. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH
Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402
[TBL] [Abstract][Full Text] [Related]
15. Experience with concomitant ultrasound-guided foam sclerotherapy and endovenous laser treatment in chronic venous disorder and its influence on Health Related Quality of Life: interim analysis of more than 1000 consecutive procedures.
King T; Coulomb G; Goldman A; Sheen V; McWilliams S; Guptan RC
Int Angiol; 2009 Aug; 28(4):289-97. PubMed ID: 19648872
[TBL] [Abstract][Full Text] [Related]
16. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids.
Lyseng-Williamson KA; Perry CM
Drugs; 2003; 63(1):71-100. PubMed ID: 12487623
[TBL] [Abstract][Full Text] [Related]
17. Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins.
Paravastu SC; Horne M; Dodd PD
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010878. PubMed ID: 27898181
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of endovenous ablation of the saphenous veins for prevention and healing of venous ulcers.
Marston WA
J Vasc Surg Venous Lymphat Disord; 2015 Jan; 3(1):113-6. PubMed ID: 26993692
[TBL] [Abstract][Full Text] [Related]
19. VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease.
Mezalek ZT; Feodor T; Chernukha L; Chen Z; Rueda A; Sánchez IE; Ochoa AJG; Chirol J; Blanc-Guillemaud V; Lohier-Durel C; Ulloa JH
Adv Ther; 2023 Nov; 40(11):5016-5036. PubMed ID: 37728696
[TBL] [Abstract][Full Text] [Related]
20. The effect of endovenous laser ablation of incompetent perforating veins and the great saphenous vein in patients with primary venous disease.
Shi H; Liu X; Lu M; Lu X; Jiang M; Yin M
Eur J Vasc Endovasc Surg; 2015 May; 49(5):574-80. PubMed ID: 25754773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
